Digital PCR applications for cell and gene therapy –standardization for a high-quality process development

Wednesday, March 20, 2024 at 12:00 PM to 12:20 PM · 20 min. (Europe/London)
Viral Vector Manufacturing [Track 9]
Presentation
Qiagen
120
QIAGEN pushes the boundaries of innovation to improve our understanding of DNA, RNA and proteins – the building blocks of life. We enable our customers to unlock valuable insights from any biological sample – be it blood, a throat swab or many other materials. We support their success with a broad range of products for molecular testing, serving applications from basic life sciences research to clinical healthcare. Never before have QIAGEN’s molecular testing solutions made a stronger impact on people’s lives than in the global fight against COVID-19. It is one of the many ways we are­ advancing science and improving outcomes for people across the world. We are known for highest quality products and outstanding service from a global organization of 6.000 passionate people in 35 countries. Our reputation is based on confidence in decisions, clarity of results and pride in the insights our customers achieve. More than 35 Nobel Prize winners among more than 500,000 customers worldwide are proof of that success.  We will continue to define the advancements of tomorrow – in line with our vision of making improvements in life possible.

Documents & Links

  • Digital PCR applications for cell and gene therapy –standardization for a high-q

Registered attendees

Alberto Malerba
Alberto Malerba
Senior Lecturer in Gene TherapyThe Royal Veterinary College
Holger Laux
Holger Laux
Director of Genetic MedicineCSL Behring
Russell Jarres
Russell Jarres
Sr. Manager, Strategic CollaborationsThermo Fisher Scientific

Log in

See all the content and easy-to-use features by logging in or registering!